Evidence map›Paper›PMID 39872618›Full record

ArticleIn vitro models2022

Introducing CELLBLOKS

Valon Llabjani, M R Siddique, Anaïs Macos, Afaf Abouzid, Valmira Hoti, Francis L Martin, Imran I Patel, Ahtasham Raza

Abstract read
In one paragraph

Article in In vitro models, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. iScience · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Valon LlabjaniREVIVOCELL Limited, Sci-Tech Daresbury, Keckwick Lane, Daresbury, Warrington, WA4 4AD UK.ORCID 0000-0001-6541-355X
M R SiddiqueREVIVOCELL Limited, Sci-Tech Daresbury, Keckwick Lane, Daresbury, Warrington, WA4 4AD UK.
Anaïs MacosREVIVOCELL Limited, Sci-Tech Daresbury, Keckwick Lane, Daresbury, Warrington, WA4 4AD UK.
Afaf AbouzidREVIVOCELL Limited, Sci-Tech Daresbury, Keckwick Lane, Daresbury, Warrington, WA4 4AD UK.
Valmira HotiREVIVOCELL Limited, Sci-Tech Daresbury, Keckwick Lane, Daresbury, Warrington, WA4 4AD UK.
Francis L MartinREVIVOCELL Limited, Sci-Tech Daresbury, Keckwick Lane, Daresbury, Warrington, WA4 4AD UK.
Imran I PatelREVIVOCELL Limited, Sci-Tech Daresbury, Keckwick Lane, Daresbury, Warrington, WA4 4AD UK.
Ahtasham RazaREVIVOCELL Limited, Sci-Tech Daresbury, Keckwick Lane, Daresbury, Warrington, WA4 4AD UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human organs are structurally and functionally complex systems. Their function is driven by the interactions between many specialised cell types, which is difficult to unravel on a standard Petri dish format. Conventional "Petri dish" approaches to culturing cells are static and self-limiting. However, current organ-on-a-chip technologies are difficult to use, have a limited throughput and lack compatibility with standard workflow conditions. We developed CELLBLOKS Supplementary Information: The online version contains supplementary material available at 10.1007/s44164-022-00027-8.

Indexed as

CELLBLOKS®Co-cultureCYP3A4LiverOrgan-on-a-chip platformTamoxifen

Identifiers

PMID39872618
PMCPMC11756440

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.